Sophia Genetics dips on $50 mln stock sale
BUZZ-Sophia Genetics dips on $50 mln stock sale ** AI-driven healthcare tech firm Sophia Genetics' SOPH.O shares down 0.5% premarket to $4.90 after $50 mln follow-on priced
** Switzerland-headquartered SOPH late Tues sold ~10.5 mln shares at $4.75, a 3.7% discount to last sale
** It intends to use net offering proceeds for working capital and other general purposes, including R&D and expand its data-driven medicine platform, per the prospectus
** TD Cowen lead bookrunner, joined by Guggenheim
** SOPH has ~71.79 mln shares outstanding for about $350 mln market cap
** At Tues close, shares up 5.6% YTD and about 70% over the past 12 months
** 2 analysts rate the shares "strong buy", the other 2 rate "buy"; median PT $8, per LSEG data
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Recent news on Toronto-Dominion Bank
See all newsCanadian lender TD tells some employees it will use software to monitor their work
Canada's banking regulator lowers stability buffer for big banks, allowing them to lend more (updated)
Canada's financial regulator lowers stability buffer for big banks, allowing them to lend more
Inter-American Dev - Issue of Debt
Sophia Genetics dips on $50 mln stock sale